BMAC vs HA in Infiltrative Therapy for Osteoarthritis of the Ankle: Randomized Controlled Clinical Trial

  • End date
    Jul 15, 2027
  • participants needed
  • sponsor
    Istituto Ortopedico Rizzoli
Updated on 15 October 2022


The aim of the study is to compare the efficacy of the infiltrative therapy of BMAC vs HA up to 24 months in the treatment of the ankle osteoarthritis. The efficacy will be assessed through clinical, objective and subjective evaluations. After 12 months patients in the control group can decide to cross-over in the treatment group.


All the patients who meet the inclusion criteria and giving written informed consent will be randomized. We planned to enrol 120 patients.

Following the randomization, every patient will be treated with a single injection of Bone Marrow Aspirate Concentrate (BMAC) or two injections of Hyaluronic Acid (HA) in the affected ankle.

After the treatment patients will be followed up to 24 months whit clinical and radiological assessment.

After 12 months patients in the control group can decide to cross-over in the treatment group with BMAC. These patients will be followed up further 12 months.

Condition Ankle Osteoarthritis
Treatment HA, BMAC
Clinical Study IdentifierNCT04883892
SponsorIstituto Ortopedico Rizzoli
Last Modified on15 October 2022


Yes No Not Sure

Inclusion Criteria

Patients with degenerative ankle cartilage disease
Unilateral involvement on the ankle
Signs and symptoms of degenerative pathology of the ankle cartilage
Radiographic or MRI signs of degenerative pathology of the ankle cartilage (OA Van Dijk grade 1-3)
No clinically significant electrocardiographic changes (recently performed ECG)
Ability and consent of patients to actively participate in clinical follow-up

Exclusion Criteria

Patients unable to give consent
Patients who have undergone intra-articular infiltration of another substance in the preceding 6 months
Patients who have undergone ankle surgery in the preceding 12 months
Patients with malignant neoplasms
Patients with rheumatic diseases
Patients with uncompensated diabetes
Patients with uncompensated thyroid metabolic disorders; 10. Patients who abuse alcoholic beverages, drugs or medications; 11. Body Mass Index > 35
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note